Loading...
XHKG
1666
Market cap496mUSD
Oct 09, Last price  
3.05HKD
1D
0.33%
1Q
-6.73%
Jan 2017
-78.79%
IPO
357.50%
Name

Tong Ren Tang Technologies Co.

Chart & performance

D1W1MN
XHKG:1666 chart
P/E
8.41
P/S
0.51
EPS
0.31
Div yield, %
6.47%
Shrs. gr., 5y
—
Rev. gr., 5y
7.07%
Revenues
6.48b
-10.69%
1,034,768,0001,157,030,0001,211,455,0001,307,897,0001,578,914,0001,936,418,0002,447,132,0002,910,749,0003,341,166,0004,066,960,0004,665,295,0005,025,183,0005,059,638,0004,476,449,0004,607,369,0005,400,487,0005,991,841,0006,773,463,0007,259,644,0006,483,875,000
Net income
396m
-24.06%
143,456,000153,520,000160,528,000173,027,000198,342,000254,687,000330,171,000390,093,000462,187,000540,481,000595,654,000666,666,000677,815,000417,650,000467,553,000507,249,000582,888,000590,188,000521,795,000396,277,000
CFO
1.56b
+9,911.10%
127,391,000-42,264,000115,851,000231,293,000266,837,000255,830,000401,648,000375,451,000333,875,000303,843,000410,005,000679,807,000985,236,0001,051,775,000435,810,0001,033,415,000723,769,000554,175,00015,607,0001,562,433,000
Dividend
Jun 16, 20260.20694 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tong Ren Tang Technologies Co. Ltd., a company founded in 1669 and based in Beijing, People's Republic of China, maintains extensive operations across Mainland China and Hong Kong. Its primary activities center on the manufacturing and sale of traditional Chinese medicine products. The company's involvement is comprehensive, extending to the cultivation, sourcing, and distribution of Chinese medicinal raw materials. Beyond its core offerings, Tong Ren Tang diversifies its product portfolio with items such as ointments, tea beverages, and specialized foot care solutions. The enterprise is also active in the technological advancement and commercialization of biological products, alongside Western pharmaceuticals, cosmetics, and general healthcare goods. Its distribution network includes both wholesale and retail channels for Chinese medicines and health-related products. Furthermore, Tong Ren Tang provides a broad spectrum of services, including medical research and development, Chinese medical consultation and treatment, advertising, internal and external surgical procedures, medical examinations, and hospital management. Additionally, the company engages in the processing of biochemical products, plant extraction, and the production of various food and daily chemical items.

Key people

De Chun Yang
Deputy General Manager
Jia Zhi Fang
Executive Director · since 2009
Bin Li
Executive Director · since 2015
Qian Wu
Executive Director · since 2018
Jian Bai
Deputy General Manager · since 2017
Gui Qin Guo
Deputy General Manager
Cun Ying Liu
Deputy General Manager
Jing Yan Zhang
Company Secretary, Secretary to the Board of Directors · since 2008
Quan Wang
Executive Vice Chairman of the Board · since 2014
Independent Non-Executive Director · since 2000
Yuanjing Zhan
Independent Non-Executive Director · since 2018
IPO date
Oct 31, 2000
Employees
4,030
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
北京市北京经济技术开发区同济北路16号
大兴区, BJ 100000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT